NRIX
Nurix Therapeutics
$25.55
+$0.21 (+0.83%)Oct 26, 2026
Key metrics
The numbers that frame NRIX today
- Market cap
- $2.79B
- P/E (TTM)
- 11.1
- EV / FCF
- 5.8
- Gross margin
- 100%
- EV / Sales
- 3.0
- ROIC
- 68.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $10.38
- 52wk High
- $28.23
Growth
Revenue and earnings trend for NRIX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NRIX
Is Nurix Therapeutics a good buy?
Yes. Nurix Therapeutics has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Nurix Therapeutics is selling at a low price.
What is the market capitalization of NRIX?
Nurix Therapeutics's market capitalization is $2.79B.
What is the P/E (TTM) ratio for NRIX stock?
Nurix Therapeutics's P/E (TTM) ratio is 11.1, based on trailing earnings.
What is the 52-week high for NRIX stock?
The 52-week high for Nurix Therapeutics is $28.23. The current close of $25.55 is 9.5% below that high.
What is the 52-week low for NRIX stock?
The 52-week low for Nurix Therapeutics is $10.38. The current close of $25.55 is 146.1% above that low.
Does NRIX stock pay dividends?
Nurix Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NRIX?
Nurix Therapeutics's Debt / Equity ratio is 0.07.